MedPath

Cesarean Section Rate in Oxytocin Infusion between Continuous Until Delivery and Discontinuation at Active Phase of Labor: a Randomized Controlled Study

Phase 4
Completed
Conditions
cesarean section rate&#44
neonatal outcomes
maternal complications&#44
labor
oxytocin&#44
Registration Number
TCTR20150503001
Lead Sponsor
Bhumibol Adulyadej Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Female
Target Recruitment
340
Inclusion Criteria

gestational age of 37 to 42 weeks, singleton with cephalic presentation, latent phase of labor, estimated fetal weight < 4000 g by Leopold�s maneuver or ultrasonography and bishop score > 4

Exclusion Criteria

fetal malpresentation, previous cesarean section or uterine scar such as previous myomectomy, placenta previa, placental abruption, persistent non-reassuring fetal heart rate pattern, active phase of labor, premature rupture of membrane (PROM), documented fetal anomalies, severe maternal diseases or maternal complications such as severe pre-eclampsia, diabetes mellitus, heart disease, HIV infection, genital lesions that obstruct passage of labor such as large genital wart or active genital herpes and contracted pelvis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the rate of cesarean section between the parturient in the continued group and discontinued oxytocin 24 hour after enrollment the rate of cesarean section between the parturient in the continued group and discontinued oxytocin
Secondary Outcome Measures
NameTimeMethod
duration of each stage of labor 24 hour after enrollment duration of each stage of labor,maternal complications 24 hour after enrollment numbers of cases who had intrapartum complications aor postpartum complications,neonatal outcomes 24 hour after enrollment numbers of cases who had adverse outcomes of neonates
© Copyright 2025. All Rights Reserved by MedPath